|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI
|
|
2
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: A site-specific analysis of the SEER
database. Int J Cancer. 114:806–816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janz TA, Graboyes EM, Nguyen SA, Ellis MA,
Neskey DM, Harruff EE and Lentsch EJ: A comparison of the NCDB and
SEER database for research involving head and neck cancer.
Otolaryngol Head Neck Surg. 160:284–294. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
NCCN Clinical Practice Guidelines in
Oncology (NCCN Guidelines®), . Head and neck cancers, version
2.2025. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdfNovember
30–2025
|
|
5
|
Pich A, Chiusa L and Navone R: Prognostic
relevance of cell proliferation in head and neck tumors. Ann Oncol.
15:1319–1329. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oike Y, Akao M, Kubota Y and Suda T:
Angiopoietin-like proteins: Potential new targets for metabolic
syndrome therapy. Trends Mol Med. 11:473–479. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan MJ, Teo Z, Sng MK, Zhu P and Tan NS:
Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer
Res. 10:677–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liao YH, Chiang KH, Shieh JM, Huang CR,
Shen CJ, Huang WC and Chen BK: Epidermal growth factor-induced
ANGPTL4 enhances anoikis resistance and tumour metastasis in head
and neck squamous cell carcinoma. Oncogene. 36:2228–2242. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiang KH, Shieh JM, Shen CJ, Chang TW, Wu
PT, Hsu JY, Tsai JP, Chang WC and Chen BK: Epidermal growth
factor-induced COX-2 regulates metastasis of head and neck squamous
cell carcinoma through upregulation of angiopoietin-like 4. Cancer
Sci. 111:2004–2015. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SH, Park YY, Kim SW, Lee JS, Wang D
and DuBois RN: ANGPTL4 induction by prostaglandin E2 under hypoxic
conditions promotes colorectal cancer progression. Cancer Res.
71:7010–7020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu X, Guo X, Wu S and Wei L: ANGPTL4
correlates with NSCLC progression and regulates
epithelial-mesenchymal transition via ERK pathway. Lung.
194:637–646. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Chen T, Shi Q, Li J, Cai S, Zhou P,
Zhong Y and Yao L: Angiopoietin-like 4 enhances metastasis and
inhibits apoptosis via inducing bone morphogenetic protein 7 in
colorectal cancer cells. Biochem Biophys Res Commun. 467:128–134.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Z, Xie J, Lin S, Li S, Huang Z, Wang
Y and Ye J: The downregulation of ANGPTL4 inhibits the migration
and proliferation of tongue squamous cell carcinoma. Arch Oral
Biol. 71:144–149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nie D, Zheng Q, Liu L, Mao X and Li Z:
Up-regulated of angiopoietin-like protein 4 predicts poor prognosis
in cervical cancer. J Cancer. 10:1896–1901. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ito Y, Oike Y, Yasunaga K, Hamada K,
Miyata K, Matsumoto S, Sugano S, Tanihara H, Masuho Y and Suda T:
Inhibition of angiogenesis and vascular leakiness by
angiopoietin-related protein 4. Cancer Res. 63:6651–6657.
2003.PubMed/NCBI
|
|
16
|
Kubo H, Kitajima Y, Kai K, Nakamura J,
Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M and Noshiro H:
Regulation and clinical significance of the hypoxia-induced
expression of ANGPTL4 in gastric cancer. Oncol Lett. 11:1026–1034.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ng KTP, Xu A, Cheng Q, Guo DY, Lim ZX, Sun
CK, Fung JH, Poon RT, Fan ST, Lo CM and Man K: Clinical relevance
and therapeutic potential of angiopoietin-like protein 4 in
hepatocellular carcinoma. Mol Cancer. 13:1962014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai YC, Yang H, Wang KF, Chen TH, Jiang WQ
and Shi YX: ANGPTL4 overexpression inhibits tumor cell adhesion and
migration and predicts favorable prognosis of triple-negative
breast cancer. BMC Cancer. 20:8782020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsieh HY, Jou YC, Tung CL, Tsai YS, Wang
YH, Chi CL, Lin RI, Hung SK, Chuang YM, Wu SF, et al: Epigenetic
silencing of the dual-role signal mediator, ANGPTL4 in tumor
tissues and its overexpression in the urothelial carcinoma
microenvironment. Oncogene. 37:673–686. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB, Byrd DR, Compton CC, Fritx AG,
Greene FL and Trotti A: AJCC cancer staging manual. 8th edition.
Springer; New York, NY: 2018
|
|
21
|
El-Naggar AK, JKC C, Grandis JR, Takata T,
Grandis J and Slootweg P: WHO classification of head and neck
tumours. 4th edition. IARC; Lyon: 2017
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakayama T, Hirakawa H, Shibata K, Nazneen
A, Abe K, Nagayasu T and Taguchi T: Expression of angiopoietin-like
4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous
invasion and distant metastasis. Oncol Rep. 25:929–935. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim HAJ, Zeng PYF, Shaikh MH, Mundi N,
Ghasemi F, Di Gravio E, Khan H, MacNeil D, Khan MI, Patel K, et al:
All HPV-negative head and neck cancers are not the same: Analysis
of the TCGA dataset reveals that anatomical sites have distinct
mutation, transcriptome, hypoxia, and tumor microenvironment
profiles. Oral Oncol. 116:1052602021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adhikary T, Brandt DT, Kaddatz K, Stockert
J, Naruhn S, Meissner W, Finkernagel F, Obert J, Lieber S, Scharfe
M, et al: Inverse PPARβ/δ agonists suppress oncogenic signaling to
the ANGPTL4 gene and inhibit cancer cell invasion. Oncogene.
32:5241–5252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kent LN and Leone G: The broken cycle: E2F
dysfunction in cancer. Nat Rev Cancer. 19:326–338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oshi M, Takahashi H, Tokumaru Y, Yan L,
Rashid OM, Nagahashi M, Matsuyama R, Endo I and Takabe K: The E2F
pathway score as a predictive biomarker of response to neoadjuvant
therapy in ER+/HER2-breast cancer. Cells. 9:16432020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun L, Hu H, Peng L, Zhou Z, Zhao X, Pan
J, Sun L, Yang Z and Ran Y: P-cadherin promotes liver metastasis
and is associated with poor prognosis in colon cancer. Am J Pathol.
179:380–390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu L, Oh C, Lim MA, Zheng S, Piao Y, Ohm
S, Shan Y, Piao S, Shen S, Kim YI, et al: Dual blockage of
P-cadherin and c-Met synergistically inhibits the growth of head
and neck cancer. Cell Oncol (Dordr). 48:1019–1033. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang H, Yu T and Mao L:
Placental-Cadherin, a biomarker for local immune status and poor
prognosis among patients with tongue squamous cell carcinoma. Eur
Arch Otorhinolaryngol. 279:3597–3609. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong X, Hong Y, Sun H, Chen C, Zhao X and
Sun B: NDRG1 suppresses vasculogenic mimicry and tumor
aggressiveness in gastric carcinoma. Oncol Lett. 18:3003–3016.
2019.PubMed/NCBI
|
|
32
|
Hu ZY, Xie WB, Yang F, Xiao LW, Wang XY,
Chen SY and Li ZG: NDRG1 attenuates epithelial-mesenchymal
transition of nasopharyngeal cancer cells via blocking Smad2
signaling. Biochim Biophys Acta. 1852:1876–1886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee JC, Chung LC, Chen YJ, Feng TH and
Juang HH: N-myc downstream-regulated gene 1 downregulates cell
proliferation, invasiveness, and tumorigenesis in human oral
squamous cell carcinoma. Cancer Lett. 355:242–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
